Topics
High-grade gliomas | Treatment | Targeted therapy | Bevacizumab
Home > Publications > Topics > High-grade gliomas > Treatment > Targeted therapy > Bevacizumab
Liao Y, Bai X, Cao Y, Zhang
M.
Effect
of low-dose bevacizumab on health-related quality of life in
patients with recurrent high-grade glioma: A retrospective
clinical study.
J
Clin Neurosci.
2024 Jan 25;120:196-203. doi: 10.1016/j.jocn.2024.01.018? PMID:
38277995. Observational study. ˍ
Bai X, Xing H, Feng M, Ma W, Wang S.
Dose
and Efficacy of Bevacizumab in Recurrent High-Grade Gliomas: A
Retrospective Study.
Cancer
Manag Res. 2024 Nov 16;16:1617-1626. doi:
10.2147/CMAR.S481289. PMID:
39575164. Observational study. ˍ
Henriksen OM, Maarup S, Hasselbalch B, Poulsen HS, Christensen IJ,
Madsen K, Larsen VA, Lassen U, Law I.
Magnetic
resonance imaging and o-(2-[18F]fluoroethyl)-l-tyrosine
positron emission tomography for early response assessment of
nivolumab and bevacizumab in patients with recurrent high-grade
astrocytic glioma.
Neurooncol
Adv. 2024 Oct 24;6(1):vdae178. doi:
10.1093/noajnl/vdae178. PMID:
39659835. Interventional study. ˍ
Lim S, Clarke NH, Maloney SL, Sener UT, Caron SJ, Kizilbash SH,
Campian JL, Neth BJ, Carabenciov ID, Uhm J, Ruff MW.
Bevacizumab
exerts dose-dependent risk for intracranial hemorrhage in patients
with malignant gliomas.
J
Neurooncol. 2025 Jan 2. doi:
10.1007/s11060-024-04916-8. PMID:
39747716. Observational study˰
ˍ
Sahebjam S, Raval RR, Forsyth PA, Enderling H, Tran ND, Arrington
JA, Macaulay R, Perlow HK, Palmer JD, Ghose J, Rajappa P, Giglio
P, Li Z, Etame AB, Mokhtari S, Cruz-Chamorro RJ, Bhandari M, Thapa
R, Robinson TJ, Chen DT, Yu HM.
Phase
1 trial of hypofractionated stereotactic re-irradiation in
combination with nivolumab, ipilimumab, and bevacizumab for
recurrent high-grade gliomas.
Neurooncol
Adv. 2025 Feb 8;7(1):vdaf033. doi:
10.1093/noajnl/vdaf033. PMID:
40134851. Interventional study. ˍ
Aghedi M, Larijani A, Bagheri AB, Rafiemanesh H, Saraee E, Mardi
S, Shirani M.
Efficacy of combined
therapy with gamma knife radiosurgery and bevacizumab on survival
outcomes in patients with recurrent high-grade glioma: a
systematic review and meta-analysis.
Neurosurg
Rev. 2025 May 29;48(1):459. doi:
10.1007/s10143-025-03632-9. PMID:
40439764.
Review;
Meta-Analysis.
ˍ